學術活動
本階層共有 26 筆資料 | 第1/3頁
Abstract: Chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and non-cystic fibrosis bronchiectasis, are highly heterogeneous conditions that require individualized care. Our nationwide cohort data highlight East Asian-specific characteristics, such as a high prevalence of Klebsiella pneumoniae and Pseudomonas aeruginosa colonization, which strongly correlate with severe exacerbations and higher mortality rates. We also utilize the validated ROSE criteria to identify the overlapping COPD-bronchiectasis association. Clinically, we refine patient management through tailored functional and therapeutic assessments. Novel functional indices, such as pace variability during the 6-minute walk test (6MWT) and the BHDE-index (incorporating post-exercise heart rate recovery), effectively stratify mortality and hospitalization risks. We also employ the remote dielectric sensing (ReDS) system to measure dynamic lung fluid changes during the 6MWT, which helps distinguish overlapping heart failure in COPD patients. Therapeutically, implementing Peak Inspiratory Flow Rate (PIFR)-guided inhalation therapy significantly reduces severe exacerbations by ensuring optimal, individualized drug delivery.
本院為協助衛生福利部推動國內癌症研究，將於115年5月30日(六) 假集思台大會議中心蘇格拉底廳辦理「再生醫療
本院為協助衛生福利部推動國內癌症研究，將於115年5月30日(六)假集思台大會議中心 B1蘇格拉底廳辦理「再生醫
「國家高齡醫學暨健康福祉研究中心－2026成果研討會」將於5月21日（四）於雲林院區舉辦，歡迎踴躍報名參加！
歐洲分子生物學組織（EMBO）成立於1964年，總部位於德國海德堡，致力於推動生命科學研究與促進國際學術交流，
New emerging vector-borne and zoonotic infectious diseases in Taiwan: a One Health approach Speake
PI Promotion Speech 題目: 多尺度環境與職業健康評估: 農藥暴露生物監測與氣候變遷衝擊之整合研
農藥登記環境影響試驗 (Environmental fate studies for pesticide registration) Speaker:顏瑞泓教授(國
The development of clinical AI cycle: from signal discovery to pragmatic trials and real-world deploy
「One Health領航：抗生素抗藥性疾病負擔與精準防疫策略」研討會以「精準迎戰抗生素抗藥性浪潮：從疾病負擔到全球協作的永續防疫新路徑」為主題，聚焦日益嚴峻的抗生素抗藥性（AMR）挑戰。AMR對全球公共衛生與經濟造成深遠影響，因其跨領域特性，更需「One Health」整合醫學、農業動物與環境科學等多方觀點，共同應對AMR及推動防疫策略。本次研討會將集結國內外專家進行交流，分享研究與實務經驗，促進台灣與國際防疫接軌。此研討會不僅因應全球健康議題，也為強化我國抗生素抗藥性防治專業能量與國際影響力，奠定重要基礎。